These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30791746)

  • 21. Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing.
    Bouquet J; Li T; Gardy JL; Kang X; Stevens S; Stevens J; VanNess M; Snell C; Potts J; Miller RR; Morshed M; McCabe M; Parker S; Uyaguari M; Tang P; Steiner T; Chan WS; De Souza AM; Mattman A; Patrick DM; Chiu CY
    PLoS One; 2019; 14(3):e0212193. PubMed ID: 30897114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation of autoimmune responses to oxidative specific epitopes, but not nitroso-adducts, is associated with a better clinical outcome in Myalgic Encephalomyelitis/chronic fatigue syndrome.
    Maes M; Leunis JC
    Neuro Endocrinol Lett; 2014; 35(7):577-85. PubMed ID: 25617880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
    J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.
    Giloteaux L; Goodrich JK; Walters WA; Levine SM; Ley RE; Hanson MR
    Microbiome; 2016 Jun; 4(1):30. PubMed ID: 27338587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Morris G; Maes M
    Med Hypotheses; 2012 Nov; 79(5):607-13. PubMed ID: 22951418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus?
    Hatziagelaki E; Adamaki M; Tsilioni I; Dimitriadis G; Theoharides TC
    J Pharmacol Exp Ther; 2018 Oct; 367(1):155-167. PubMed ID: 30076265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.
    Maes M
    Mod Trends Pharmacopsychiatry; 2013; 28():162-74. PubMed ID: 25224898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
    Maes M; Bosmans E; Kubera M
    Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Mensah FFK; Armstrong CW; Reddy V; Bansal AS; Berkovitz S; Leandro MJ; Cambridge G
    Front Immunol; 2018; 9():2421. PubMed ID: 30405620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism.
    Germain A; Ruppert D; Levine SM; Hanson MR
    Mol Biosyst; 2017 Jan; 13(2):371-379. PubMed ID: 28059425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.
    Morris G; Maes M
    Metab Brain Dis; 2013 Dec; 28(4):523-40. PubMed ID: 22718491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: the role of elastase, complement C4a and interleukin-1beta.
    Nijs J; Van Oosterwijck J; Meeus M; Lambrecht L; Metzger K; Frémont M; Paul L
    J Intern Med; 2010 Apr; 267(4):418-35. PubMed ID: 20433584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circadian rhythm abnormalities and autonomic dysfunction in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Cambras T; Castro-Marrero J; Zaragoza MC; Díez-Noguera A; Alegre J
    PLoS One; 2018; 13(6):e0198106. PubMed ID: 29874259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease.
    Underhill RA
    Med Hypotheses; 2015 Dec; 85(6):765-73. PubMed ID: 26604026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review.
    Tomas C; Newton J
    Biochem Soc Trans; 2018 Jun; 46(3):547-553. PubMed ID: 29666214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.
    Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Ramos S; Staines D; Marshall-Gradisnik S
    Int J Med Sci; 2015; 12(10):764-72. PubMed ID: 26516304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.
    Eaton N; Cabanas H; Balinas C; Klein A; Staines D; Marshall-Gradisnik S
    BMC Pharmacol Toxicol; 2018 Mar; 19(1):12. PubMed ID: 29587879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia?
    Castro-Marrero J; Cordero MD; Sáez-Francas N; Jimenez-Gutierrez C; Aguilar-Montilla FJ; Aliste L; Alegre-Martin J
    Antioxid Redox Signal; 2013 Nov; 19(15):1855-60. PubMed ID: 23600892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between clinical symptoms, plasma norepinephrine and deregulated immune gene networks in subgroups of adolescent with Chronic Fatigue Syndrome.
    Nguyen CB; Kumar S; Zucknick M; Kristensen VN; Gjerstad J; Nilsen H; Wyller VB
    Brain Behav Immun; 2019 Feb; 76():82-96. PubMed ID: 30419269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S
    Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.